Transocean (RIG) has surged 42.9% recently, outperforming the S&P 500, yet I maintain a 'hold' rating due to lingering risks.

Get insights on Biogen’s Leqembi sales outlook, clinical value, risks, and what new drug approvals may mean for investors.

EMD's 10.7% yield is attractive, but payout sustainability is questionable as distributions often exceed net investment ...

California BanCorp.'s $3.0B loan portfolio is 58.6% commercial real estate, with the majority of that loan segment being ...

Discover why Equinox Gold (EQX) is rated a Buy for 2026, driven by production growth, falling costs, and strong Q3 results.

Explore Avantis Emerging Markets Equity ETF (AVEM): top YTD returns, tech & Asia focus, and risk-diversified exposure.

Discover why VictoryShares Dividend Accelerator ETF stands out for dividend growth & stability. Compare with NOBL & SDY.

Richtech Robotics operates in a rapidly evolving robotics sector dominated by big tech and aggressive capital deployment.

GXC (SPDR S&P China ETF) remains a buy, supported by improving profit expectations and solid year-to-date outperformance ...

Broadcom experienced an 11% single-day drop, but unlike Oracle, this is not driven by fundamental concerns. Read more on AVGO ...

Broadcom's AI revenue soars 74% YoY, aiming to double by FQ1'26. However, the semiconductor company got hit with overblown ...

Discover how Fidelity Freedom® 2040 Fund performed in Q3 2025! Click here for more on investment approach, market outlook, ...